Anavex Life Sciences Corp (AVXL)

[stealthways]

Valuation:
The valuation done in the latest article on SA should be taken with a "grain of salt". For example as previously mentioned, America spent 214 billion on Alzheimers in 2014 and world wide Alzheimer costs are likely getting close to a Trillion dollars (which would be about 5 times US amount)... and this is growing fast with the aging populations.... Now the SA article gives a value to a drug (with almost zero competition) thats looks likely to cure and stem costs in this near one trillion cost market, a value of only just over 300 million.....IMO a comical valuation when you have a near monopoly.. Look at Gilead which also has a near monopoly and the cost market of Hep C is likely 5% of Alzheimers......Also why did the SA author not even ask Anavex about Epilepsy and its worlds best pre-clinical trials...and the New world Epilepsy expert who joined the company.......not even a mention....